Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05389930 · ClinicalTrials.gov registry record · Phase 2
Cannabis' Impact on Alcohol Consumption
A Phase 2 study of Alcohol Use Disorder and Alcohol Drinking, sponsored by Brown University.
- Recruiting
- Registry status
- Phase 2
- Development phase
- 350
- Enrollment target
- 1
- Study location
NCT05389930: Recruiting Phase 2 study of Alcohol Use Disorder and Alcohol Drinking, sponsored by Brown University.
NCT05389930 is a Phase 2 study of Alcohol Use Disorder and Alcohol Drinking that is actively recruiting participants, run by Brown University. The registered enrollment target is 350 participants, roughly in line with the 327-participant average among 184 other Alcohol Use Disorder trials with a reported enrollment target. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05389930, a Phase 2 study of Alcohol Use Disorder and Alcohol Drinking, is actively recruiting participants, sponsored by Brown University.
- RECRUITING
- Registry status
- Phase 2
- Development phase
- 350 participants
- Enrollment target
- 1
- Study location
Study Summary
This study employs a repeated measures experimental design to examine the effect of THC-dominant dose of cannabis and CBD-dominant dose of cannabis, relative to placebo, on subsequent drinking in an alcohol choice task in which participants choose either to drink or receive monetary reinforcement for drinks not consumed. Cannabis will be administered simultaneously with an alcohol-priming dose or alcohol placebo. The study will enroll up to 350 nontreatment-seeking heavy episodic alcohol drinkers who use cannabis weekly.
Primary Outcome
ml of alcohol consumed during the alcohol choice task
Conditions Studied
Interventions
- DRUG THC-dominant cannabis
- DRUG CBD-dominant cannabis
- DRUG Cannabis placebo
- DRUG Alcohol
- DRUG Alcohol placebo
Study Locations (1)
Rhode Island
- Brown University - Providence
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 350 participants |
| Start Date | 2023-03-16 |
| Est. Completion | 2027-03-31 |
| Phase | Phase 2 |
What NCT05389930 shows while recruiting
NCT05389930 is an interventional study that assigns participants to a tested intervention. The registered 350 participants enrollment target is mid-sized for trials with a published cap, roughly in line with the 327-participant average among 184 other Alcohol Use Disorder trials with a reported enrollment target.
The record links to 4 conditions, with Alcohol Use Disorder appearing as the primary indexed condition, and to 5 interventions - of which THC-dominant cannabis is the first listed.
NCT05389930 reports a single indexed study location in Rhode Island.
Frequently Asked Questions
What is clinical trial NCT05389930 about?
NCT05389930 is a clinical study titled "Cannabis' Impact on Alcohol Consumption". This study employs a repeated measures experimental design to examine the effect of THC-dominant dose of cannabis and CBD-dominant dose of cannabis, relative to placebo, on subsequent drinking in an alcohol choice task in which participants choose either to drink or receive monetary reinforcement fo...
What is the current status of trial NCT05389930?
This trial is currently recruiting. It is a Phase 2 study. The enrollment target is 350 participants. The study started on 2023-03-16. Estimated completion is 2027-03-31.
What conditions does trial NCT05389930 study?
This clinical trial studies the following conditions: Alcohol Use Disorder, Alcohol Drinking, Cannabis Use, Cannabis.
What interventions are being tested in trial NCT05389930?
The interventions under investigation include: THC-dominant cannabis (DRUG), CBD-dominant cannabis (DRUG), Cannabis placebo (DRUG), Alcohol (DRUG), Alcohol placebo (DRUG).
Who is sponsoring clinical trial NCT05389930?
This trial is sponsored by Brown University, which has 231 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05389930 being conducted?
This trial has 1 study location across Rhode Island. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Alcohol Use Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05389930's enrollment target sits among peer trials
350 25th of 184 higher than 160 of 184 other Alcohol Use Disorder trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Alcohol Use Disorder trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Orexin Receptor Antagonism for the Treatment of Alcohol Use Disorder and Stress-Related Drinking
RECRUITING · Phase 2
-
Enhanced Digital-Chemosensory-Based Olfactory Training for Remote Management of Substance Use Disorders
RECRUITING · Phase 2
-
Psilocybin or Ketamine for Alcohol Use Disorder: An Active Comparator Trial
RECRUITING · Phase 2
-
COMT Inhibition Among Individuals With Comorbid AUD/ADHD
RECRUITING · Phase 2
-
Semaglutide Therapy for Alcohol Reduction (STAR)
RECRUITING · Phase 2
-
A Pilot Study of Non-invasive Brain Stimulation to Boost the Efficacy of Psychotherapy in a Community Sample of People Who Drink Alcohol
RECRUITING · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00900575 · 350 participants · NA
Cervical Cancer Detection Using Optical Spectroscopy
- NCT01627821 · 350 participants · NA
Evaluation of the Jarvik 2000 Left Ventricular Assist System With Post-Auricular Connector--Destination Therapy Study
- NCT02357654 · 350 participants · Phase 4
GnRH for Luteal Support in IVF/ICSI/FET Cycles
- NCT03997370 · 350 participants · Phase 1
Evaluation of Dosing Procedures of Chemotherapy Treatment (Carboplatin) With the Contrast Agent Iohexol
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI